Galapagos NV GLPGF:OTCPK

*Data is delayed | Exchange | USD
Last | 04/17/24 EDT
26.20UNCH (UNCH)
52 week range
26.20 - 41.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.20
  • 52 Week High41.75
  • 52 Week High Date07/26/23
  • 52 Week Low26.20
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap1,880.36M
  • Shares Out65.9M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.20
  • 52 Week High41.75
  • 52 Week High Date07/26/23
  • 52 Week Low26.20
  • 52 Week Low Date04/17/24
  • Market Cap1,880.36M
  • Shares Out65.9M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.50
  • P/E (TTM)52.09
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galapagos NV

 

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It...
Paulus Stoffels
Chairman of the Board, Chief Executive Officer
Thad Huston
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Member of the Management Board
Valeria Cnossen
Executive Vice President, General Counsel, Member of the Management Board
Address
Generaal De Wittelaan L11 A3
Malines (mechelen)
2800
Belgium